# Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-lifileucel-a-one-time-autologous-tumor-infiltrating/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jason Chesney,Karl D. Lewis,Harriet M. Kluger,Omid Hamid,Eric D. Whitman,Sajeve Thomas,Martin Wermke,Mike Cusnir,Evidio Domingo‐Musibay,Giao Q. Phan,John M. Kirkwood,Jessica C. Hassel,Marlana Orloff,James Larkin,Jeffrey S. Weber,Andrew J.S. Furness,Nikhil I. Khushalani,Theresa Medina,Michael E. Egger,Friedrich Graf Finckenstein,Madan Jagasia,Parameswaran Hari,Giri Sulur,Wen Shi,Xiao Wu,Amod A. Sarnaik |
| Citations | 334 |
| DOI | 10.1136/jitc-2022-005755 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jitc.bmj.com/content/jitc/10/12/e005755.full.pdf |
| OpenAlex ID | https://openalex.org/W4311310504 |
| PMID | 36600653 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Martin Wermke](https://scholariq.org/researchers/martin-wermke/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Phagocytosis and Immune Regulation](https://scholariq.org/topics/phagocytosis-and-immune-regulation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.